Effects of an off-label combination treatment of three repurposed drugs on selected molecular and biological features of patient-derived glioblastoma cells in vitro
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Ulm, Universität Ulm, Dissertation, 2024
- Schlagwort
-
Krebs
Kombinationstherapie
Pharmakotherapie
Glioblastom
Hirntumor
Tumorhemmstoff
Immunmodulator
- Ereignis
-
Veröffentlichung
- (wo)
-
Ulm
- (wer)
-
Universität Ulm
- (wann)
-
2024
- Urheber
- DOI
-
10.18725/OPARU-52304
- URN
-
urn:nbn:de:bsz:289-oparu-52380-9
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zeiler, Katharina Alexandra
- Universität Ulm
Entstanden
- 2024
Ähnliche Objekte (12)
Subtype-Specific Off-Label Treatment of Rosacea
The Off-Label Use of Consumer Credit Ratings
The Off-Label Use of Consumer Credit Ratings
Off-Label = Off-Legal = Illegal?
Off-label, off-limits? Parental awareness and attitudes towards off-label use in paediatrics
Incidence of unlicensed and off-label prescription in children
Off-label drugs vs. the merits of centralised regulatory control
Off-label use of medicines in South Africa: a review
Off-label Use of Devices and Drugs in Interventional Radiology
PW03-019 – Survey of off-label ANTI-IL1 treatments in France
Off-Label Use of Phakic Intraocular Lens with a “Piggyback” Technique
Off-label use of orphan medicinal products: a Belgian qualitative study
Subtype-Specific Off-Label Treatment of Rosacea
The Off-Label Use of Consumer Credit Ratings
The Off-Label Use of Consumer Credit Ratings
Off-Label = Off-Legal = Illegal?
Off-label, off-limits? Parental awareness and attitudes towards off-label use in paediatrics
Incidence of unlicensed and off-label prescription in children
Off-label drugs vs. the merits of centralised regulatory control
Off-label use of medicines in South Africa: a review
Off-label Use of Devices and Drugs in Interventional Radiology
PW03-019 – Survey of off-label ANTI-IL1 treatments in France
Off-Label Use of Phakic Intraocular Lens with a “Piggyback” Technique
Off-label use of orphan medicinal products: a Belgian qualitative study
Subtype-Specific Off-Label Treatment of Rosacea
The Off-Label Use of Consumer Credit Ratings
The Off-Label Use of Consumer Credit Ratings
Off-Label = Off-Legal = Illegal?
Off-label, off-limits? Parental awareness and attitudes towards off-label use in paediatrics
Incidence of unlicensed and off-label prescription in children
Off-label drugs vs. the merits of centralised regulatory control
Off-label use of medicines in South Africa: a review
Off-label Use of Devices and Drugs in Interventional Radiology
PW03-019 – Survey of off-label ANTI-IL1 treatments in France
Off-Label Use of Phakic Intraocular Lens with a “Piggyback” Technique